California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on August 26, 2026

Vein Specialists Point to Dehydration and Travel as Summer Clot Risks
"WE’RE OUT OF TIME" PODCAST SUPPORTS THE CDC FOUNDATION IN TURNING OVERDOSE AWARENESS INTO ACTION
La Jolla Plastic Surgeon Named Among 'America’s Best Plastic Surgeons' in 2026 by Newsweek® Magazine
Green Edge Systems Launches New Front‑of‑Line Menu Boards to Help Schools Meet USDA Meal Visibility Requirements
BrainChip's AkidaTag Wins Global AI Award for Edge AI & IoT Intelligence
Introducing OWASP OASIS: Initiative Fighting Back Against AI and Human Exploits of Open Source Software Vulnerabilities
Rezolve.ai Recognized in the 2026 Gartner® Magic Quadrant™ for AI Applications in IT Service Management
Rezolve.ai Ranked Highest in AI for End-User Self-Service — Gartner® Critical Capabilities for AI Applications in ITSM
Rezolve.ai Ranked Highest in AI for IT Agents — Gartner® Critical Capabilities for AI Applications in ITSM
Rezolve.ai Ranked Highest in Two Use Cases in the Gartner® Critical Capabilities for AI Applications in ITSM
Onco360® Has Been Selected as a National Pharmacy Partner for RASONQUE™ (daraxonrasib)
New Study Finds Tangential Curettage Biopsy May Improve Detection of Microbial Burden in Hard-to-Heal Wounds
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients
Five Trusted Laboratory Furniture Manufacturers in China 2026: Advancing Safe & Durable Lab Infrastructure Solutions
First Tracks Biotherapeutics Announces Participation in September Investor Conferences
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology
Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting
Xenon to Highlight Phase 3 X-TOLE2 Clinical Data and Rational Polytherapy Potential for Azetukalner at EEC 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.